Maria Perez-Lanzon

7PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 20, 2025
Epigenetic regulation of HOXA2 expression affects tumor progression and predicts breast cancer patient survival.

Fatima Domenica Elisa De Palma, Jonathan G Pol, Vincent Carbonnier

|Oct 29, 2021
Crizotinib and ceritinib trigger immunogenic cell death via on-target effects.

Adriana Petrazzuolo, Maria Perez-Lanzon, Peng Liu

|Oct 25, 2019
Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity.

Wei Xie, Sabrina Forveille, Kristina Iribarren

|Mar 26, 2019
Failure of immunosurveillance accelerates aging.

Maria Perez-Lanzon, Laurence Zitvogel, Guido Kroemer

Pageof 2